文献速递区域麻醉与超声术前评估与围术期医学

静脉右美托咪定联用地塞米松对肌间沟臂丛阻滞术后镇痛的影响

Intravenous dexmedetomidine as addition to dexamethasone for interscalene brachial plexus block for postoperative analgesia after arthroscopic shoulder surgery: A randomised, double-blinded, single centre trial.
PubMed 文献 · Eur J Anaesthesiol · 2025-05-13

结果显示各组首次镇痛需求时间无显著差异,高剂量右美托咪定未带来额外镇痛获益,但可能增加血流动力学风险并延长拔管时间。

要点

  • 静脉右美托咪定1.0、1.5、2.0 μg/kg均未显著延长首次镇痛需求时间。
  • 高剂量右美托咪定可能增加术中低血压和心动过缓风险。
  • 右美托咪定2.0 μg/kg组拔管时间显著延长(>14 min)。

核心结论

  • 单次肌间沟臂丛阻滞后,静脉给予高剂量右美托咪定未产生额外镇痛获益,反而可能增加血流动力学风险并延长拔管时间。

主要发现

  • 首次镇痛需求时间各组无显著差异:组1为18.8±6.3 h,组2为18.7±5.1 h,组3为17.7±5.6 h,组4为19.5±5.0 h。
  • 术后24 h内恶心呕吐、患者满意度和睡眠质量各组无显著差异。
  • 对照组与所有右美托咪定组合并比较,术中低血压和心动过缓发生率有显著差异,但研究未针对此分析进行效能计算。
  • 组4拔管时间显著延长(>14 min),手术时间较短时更明显(OR 0.98,95% CI 0.96至0.99)。

临床怎么用

  • 在静脉地塞米松基础上加用右美托咪定时,无需为追求镇痛延长而增加剂量,应权衡血流动力学风险和拔管延迟。

局限性

  • 单中心研究。
  • 血流动力学分析未进行效能计算。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The co-administration of intravenous dexamethasone and dexmedetomidine is reported to prolong the duration of analgesia after single-shot interscalene brachial plexus block. The most effective dose with minimal side effects remains undetermined. OBJECTIVES: To evaluate the difference in time to first analgesic request in patients receiving different doses of intravenous dexmedetomidine after an interscalene brachial plexus block undergoing arthroscopic shoulder surgery. DESIGN: A double-blind, randomised controlled study. SETTING: A single-centre study from November 2021 to December 2023. PATIENTS: Two hundred and eighteen patients undergoing arthroscopic shoulder surgery were included. INTERVENTIONS: Patients were randomly assigned to one of four groups using blocked randomisation: intravenous 0.9% saline (group 1) or intravenous dexmedetomidine: 1.0 (group 2), 1.5 (group 3) and 2.0 (group 4) μg kg -1 . MAIN OUTCOME MEASURES: The primary outcome was the time to first analgesic request in hours. RESULTS: There was no significant difference in the time to first analgesic request: group 1 (18.8 ± 6.3 h), group 2 (18.7 ± 5.1 h), group 3 (17.7 ± 5.6 h) and group 4 (19.5 ± 5.0 h). There was no significant difference in postoperative nausea and vomiting, patient satisfaction and quality of sleep in the first 24 h. There were significant differences in the incidences of intra-operative hypotension and bradycardia between the control group and all the dexmedetomidine groups combined; however, this study was not powered for this analysis. The time to extubation was statistically significantly higher in group 4 with a prolonged time to extubation (>14 min) when the duration of surgery was shorter (OR 0.98, 95% CI 0.96 to 0.99). CONCLUSIONS: Administering high doses of intravenous dexmedetomidine may not yield additional analgesic benefits after single-shot interscalene brachial plexus block while potentially increasing haemodynamic risks and prolonging time to extubation. TRIAL REGISTRATION: EudraCT 2021-004686-12.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Vanden Eede H, Noels S, Vreven M, et al. Intravenous dexmedetomidine as addition to dexamethasone for interscalene brachial plexus block for postoperative analgesia after arthroscopic shoulder surgery: A randomised, double-blinded, single centre trial. Eur J Anaesthesiol. 2025. PMID: 40364792. doi:10.1097/EJA.0000000000002196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。